| Recruiting | Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized P NCT07276438 | Jonsson Comprehensive Cancer Center | N/A |
| Recruiting | Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemi NCT07073794 | Mayo Clinic | Phase 2 |
| Recruiting | Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patie NCT07025369 | Mayo Clinic | Phase 2 |
| Recruiting | Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy NCT06940271 | Mayo Clinic | N/A |
| Recruiting | Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Tr NCT06995053 | Jonsson Comprehensive Cancer Center | N/A |
| Active Not Recruiting | A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Brea NCT06630325 | OHSU Knight Cancer Institute | Phase 2 |
| Withdrawn | Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk NCT06528210 | OHSU Knight Cancer Institute | Phase 2 |
| Withdrawn | Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Pa NCT06094842 | Fred Hutchinson Cancer Center | Phase 1 |
| Recruiting | REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial NCT06650579 | Emory University | Phase 3 |
| Suspended | Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prost NCT06733350 | Roswell Park Cancer Institute | Phase 4 |
| Recruiting | Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation NCT05487846 | Thomas Jefferson University | N/A |
| Recruiting | Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate NCT06325046 | Mayo Clinic | N/A |
| Recruiting | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patie NCT05869682 | City of Hope Medical Center | Phase 2 |
| Recruiting | Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Ca NCT06389786 | Mayo Clinic | N/A |
| Recruiting | SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcino NCT06205316 | Mayo Clinic | Phase 3 |
| Recruiting | Vitamin D for Prostate Endocrine Therapy NCT05838716 | University of Rochester | Phase 3 |
| Recruiting | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prost NCT05946213 | NRG Oncology | Phase 3 |
| Not Yet Recruiting | Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer NCT06129851 | University of Kansas Medical Center | Phase 2 |
| Recruiting | Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer NCT06173362 | University of California, Davis | Phase 2 |
| Recruiting | Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors NCT06500169 | University of Southern California | N/A |
| Completed | Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial NCT06016725 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | LiSWT for Nerve Sparing Radical Prostatectomy ED NCT05877144 | Thomas Jefferson University | N/A |
| Recruiting | Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side NCT05722288 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | RElugolix VErsus LeUprolide Cardiac Trial NCT05320406 | Emory University | Phase 2 |
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Suspended | Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer NCT04981834 | University of Southern California | N/A |
| Completed | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion NCT04976257 | Ryan Kohlbrenner, MD | EARLY_Phase 1 |
| Recruiting | High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma NCT04945642 | Jonsson Comprehensive Cancer Center | N/A |
| Recruiting | Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Loc NCT04947254 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer NCT04777071 | University of Washington | Phase 2 |
| Recruiting | Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations NCT04550494 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer NCT04725903 | Emory University | N/A |
| Active Not Recruiting | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low NCT04513717 | NRG Oncology | Phase 3 |
| Terminated | Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation The NCT04927559 | University of Southern California | — |
| Terminated | Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer NCT04457245 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prost NCT04318028 | University of Southern California | N/A |
| Recruiting | Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery NCT04134260 | NRG Oncology | Phase 3 |
| Active Not Recruiting | Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and T NCT04189770 | M.D. Anderson Cancer Center | — |
| Withdrawn | Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate NCT04288336 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Active Not Recruiting | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before NCT03899987 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Thera NCT04037254 | NRG Oncology | Phase 1 / Phase 2 |
| Active Not Recruiting | Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans NCT04215029 | M.D. Anderson Cancer Center | N/A |
| Completed | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors NCT03784677 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574 | National Cancer Institute (NCI) | — |
| Completed | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer NCT04067960 | Mayo Clinic | EARLY_Phase 1 |
| Active Not Recruiting | Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer NCT03987386 | M.D. Anderson Cancer Center | Phase 3 |
| Withdrawn | Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response NCT03581500 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | EXERCISING TOGETHER for Couples Coping With Cancer NCT03630354 | OHSU Knight Cancer Institute | N/A |
| Active Not Recruiting | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small NCT03582475 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutati NCT03218826 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatec NCT03570827 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveill NCT03575832 | M.D. Anderson Cancer Center | N/A |
| Completed | Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Local NCT03177460 | M.D. Anderson Cancer Center | Phase 1 |